암 진단 분야 AI 시장 : 질병 유형별, 구성요소별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

REPORT HIGHLIGHT

AI in Cancer Diagnostics Market size was valued at USD 901.98 Million in 2023, expanding at a CAGR of 9.40% from 2024 to 2032.

Combination therapy drug treatment refers to the use of two or more medications simultaneously to treat a disease or medical condition. This approach is commonly used in various fields of medicine to enhance treatment efficacy, reduce the risk of resistance, and target multiple aspects of a disease or condition. The drugs used in combination therapies can act through different mechanisms or at different stages of disease progression, providing a synergistic effect that single-drug treatments may not achieve.

AI in Cancer Diagnostics Market- Market Dynamics

Increasing development of new drug combinations and rising demand for targeted & immunotherapies is expected to propel market demand

Artificial Intelligence (AI) has emerged as a transformative force in the field of cancer diagnostics, significantly enhancing the ability to detect and classify various types of cancer, boosting market growth. AI can analyze imaging patterns to determine the type and stage of cancer, as well as other characteristics that may influence treatment options. It also evaluates tissue samples, identifying abnormal cells and quantifying tumor characteristics, which is essential for diagnoses. AI algorithms can process large datasets of genomic information to identify mutations associated with specific cancers, aiding in personalized medicine. Thus, growing demand for genomic data is contributing to high adoption of AI in cancer diagnostics.

Further, AI powered Clinical Decision Support System (CDSS) helps integrate patient data and clinical guidelines to suggest the most effective and up-to-date treatment plans. NLP tools can aid clinicians by providing relevant literature or previous case summaries to inform treatment decisions. Thus, AI is revolutionizing the landscape of cancer diagnostics, enabling earlier detection, more accurate diagnoses, and personalized treatment strategies. As technology and methodologies continue to advance, collaboration among oncologists, researchers, and data scientists will be crucial for harnessing the full potential of AI in oncology.

AI in Cancer Diagnostics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.40% over the forecast period (2024-2032)

Based on Disease Type segmentation, the others segment was predicted to show maximum market share in the year 2023, owing to high consumption of alcohol & tobacco inviting cancer diseases.

Based on Component segmentation, software segment was the leading Component segment in 2023, due to the rapid adoption of software solution in medical sector.

Based on End User segmentation, hospitals segment was the leading End User segment in 2023, due to increasing prevalence of cancer.

On the basis of region, North America was the leading revenue generator in 2023, due to the adoption of AI technologies in healthcare industry.

AI in Cancer Diagnostics Market- Segmentation Analysis:

Global AI in Cancer Diagnostics Market is segmented on the basis of Disease Type, Component, End User, and Region.

The market is divided into five categories based on Disease Type: breast cancer, lung cancer, prostate cancer, brain tumor, and others. The others segment dominates the market. The increasing consumption of tobacco & alcohol is mainly boosting segment growth.

The market is divided into three categories based on Component: software, hardware, and services. The software segment dominates the market. The increasing adoption of cloud systems and IoT enabled AI services are boosting segment demand.

The market is divided into three categories based on End User: hospitals, surgical centers, and others. The hospital segment dominates the market and is expected to maintain its high dominance during the forecast period. The rising utilization of AI powered solutions into the workflows & platforms of hospital is supplementing market growth.

AI in Cancer Diagnostics Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America is the largest regional market due to advanced healthcare infrastructure, strong research and development capabilities. Asia-Pacific is anticipated to experience the highest compound annual growth rate (CAGR) over the forecast period due to a large cancer-affected population base and growing healthcare investments. Europe is another significant market, driven by the adoption of advanced AI technologies, a strong focus on research, and a high prevalence of cancer.

AI in Cancer Diagnostics Market- Competitive Landscape:

The competitive landscape of Artificial Intelligence (AI) in the cancer diagnostics market is shaped by several prominent companies and the rapid pace of technological advancements and strategic partnerships. Key players in the market include well-established healthcare technology companies as well as innovative startups focusing on specialized AI solutions. Market players are emphasizing developing AI solutions that can detect cancer at an early stage with high precision. This includes advancements in imaging modalities like MRI, CT scans, and digital pathology.

In 2023, NVIDIA and Medtronic collaborated to integrate AI technology in Medtronic's GI Genius intelligent endoscopy module, enhancing early detection of colorectal polyps that could develop into cancer.

In 2023, Mayo Clinic and Numares Health expanded their collaboration to develop AI-based diagnostic tests for chronic diseases, which can also enhance cancer diagnostic capabilities.

In March 2022, Microsoft acquired Nuance Communications, a leader in ambient intelligence and conversational AI.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL AI IN CANCER DIAGNOSTICS MARKET KEY PLAYERS

• EarlySign
• Cancer Center.ai
• Microsoft
• Flatiron
• Path AI
• Therapixel
• Tempus
• Paige AI, Inc.
• Maxwell Plus
• Kheiron Medical Technologies Limited
• SkinVision
• Cancer Diagnostics Inc.
• Siemens Healthineers
• GE Healthcare
• Others

GLOBAL AI IN CANCER DIAGNOSTICS MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019-2032

• Breast cancer
• Lung cancer
• Prostate cancer
• Brain tumor
• Others

GLOBAL AI IN CANCER DIAGNOSTICS MARKET, BY COMPONENT- MARKET ANALYSIS, 2019-2032

• Software
• Hardware
• Services

GLOBAL AI IN CANCER DIAGNOSTICS MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

• Hospital
• Surgical Centers
• Others

GLOBAL AI IN CANCER DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. AI in Cancer Diagnostics Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. AI in Cancer Diagnostics Market Snippet by Disease Type
  • 2.1.2. AI in Cancer Diagnostics Market Snippet by Component
  • 2.1.3. AI in Cancer Diagnostics Market Snippet by End User
  • 2.1.4. AI in Cancer Diagnostics Market Snippet by Country
  • 2.1.5. AI in Cancer Diagnostics Market Snippet by Region
• 2.2. Competitive Insights

3. AI in Cancer Diagnostics Key Market Trends

• 3.1. AI in Cancer Diagnostics Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. AI in Cancer Diagnostics Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. AI in Cancer Diagnostics Market Opportunities
• 3.4. AI in Cancer Diagnostics Market Future Trends

4. AI in Cancer Diagnostics Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. AI in Cancer Diagnostics Market: COVID-19 Impact Analysis

• 5.1. Pre-COVID-19 Impact Analysis
• 5.2. Post-COVID-19 Impact Analysis
  • 5.2.1. Top Performing Segments
  • 5.2.2. Marginal Growth Segments
  • 5.2.3. Top Looser Segments
  • 5.2.4. Marginal Loss Segments

6. AI in Cancer Diagnostics Market Landscape

• 6.1. AI in Cancer Diagnostics Market Share Analysis, 2023
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. AI in Cancer Diagnostics Market - By Disease Type

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Disease Type, 2024 & 2032 (%)
  • 7.1.2. Breast cancer
  • 7.1.3. Lung cancer
  • 7.1.4. Prostate cancer
  • 7.1.5. Brain tumor
  • 7.1.6. Others

8. AI in Cancer Diagnostics Market - By Component

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Component, 2024 & 2032 (%)
  • 8.1.2. Software
  • 8.1.3. Hardware
  • 8.1.4. Services

9. AI in Cancer Diagnostics Market - By End User

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
  • 9.1.2. Hospital
  • 9.1.3. Surgical Centers
  • 9.1.4. Others

10. AI in Cancer Diagnostics Market- By Geography

• 10.1. Introduction
  • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
• 10.2. North America
  • 10.2.1. Overview
  • 10.2.2. AI in Cancer Diagnostics Key Manufacturers in North America
  • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.2.4. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  • 10.2.5. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.2.7. U.S.
    • 10.2.7.1. Overview
    • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.7.3. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.2.7.4. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.2.8. Canada
    • 10.2.8.1. Overview
    • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.8.3. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.2.8.4. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 10.3. Europe
  • 10.3.1. Overview
  • 10.3.2. AI in Cancer Diagnostics Key Manufacturers in Europe
  • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.3.4. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  • 10.3.5. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.7. Germany
    • 10.3.7.1. Overview
    • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.7.3. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.7.4. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.8. Italy
    • 10.3.8.1. Overview
    • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.8.3. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.8.4. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.9. United Kingdom
    • 10.3.9.1. Overview
    • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.9.3. United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.9.4. United Kingdom Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.10. France
    • 10.3.10.1. Overview
    • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.10.3. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.10.4. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.11. Russia
    • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.11.2. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.11.3. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.12. Netherlands
    • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.12.2. Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.12.3. Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.13. Sweden
    • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.13.2. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.13.3. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.14. Poland
    • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.14.2. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.14.3. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.15. Rest of Europe
    • 10.3.15.1. Overview
    • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 10.4. Asia Pacific (APAC)
  • 10.4.1. Overview
  • 10.4.2. AI in Cancer Diagnostics Key Manufacturers in Asia Pacific
  • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.4.4. Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  • 10.4.5. Asia Pacific Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.7. India
    • 10.4.7.1. Overview
    • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.7.3. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.7.4. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.8. China
    • 10.4.8.1. Overview
    • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.8.3. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.8.4. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.9. Japan
    • 10.4.9.1. Overview
    • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.9.3. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.9.4. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.10. South Korea
    • 10.4.10.1. Overview
    • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.10.3. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.10.4. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.11. Australia
    • 10.4.11.1. Overview
    • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.11.3. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.11.4. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.12. Thailand
    • 10.4.12.1. Overview
    • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.12.3. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.12.4. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.13. Indonesia
    • 10.4.13.1. Overview
    • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.13.3. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.13.4. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.14. Philippines
    • 10.4.14.1. Overview
    • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.14.3. Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.14.4. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.15. Rest of APAC
    • 10.4.15.1. Overview
    • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.15.3. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.15.4. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 10.5. Latin America
  • 10.5.1. Overview
  • 10.5.2. AI in Cancer Diagnostics Key Manufacturers in Latin America
  • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.5.4. Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  • 10.5.5. Latin America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5.7. Brazil
    • 10.5.7.1. Overview
    • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.7.3. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.5.7.4. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5.8. Mexico
    • 10.5.8.1. Overview
    • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.8.3. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.5.8.4. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5.9. Argentina
    • 10.5.9.1. Overview
    • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.9.3. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.5.9.4. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5.10. Colombia
    • 10.5.10.1. Overview
    • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.10.3. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.5.10.4. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5.11. Rest of LATAM
    • 10.5.11.1. Overview
    • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 10.6. Middle East and Africa
  • 10.6.1. Overview
  • 10.6.2. AI in Cancer Diagnostics Key Manufacturers in Middle East and Africa
  • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.6.4. Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  • 10.6.5. Middle East and Africa Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6.7. Saudi Arabia
    • 10.6.7.1. Overview
    • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6.8. United Arab Emirates
    • 10.6.8.1. Overview
    • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6.9. Israel
    • 10.6.9.1. Overview
    • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.9.3. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.9.4. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6.10. Turkey
    • 10.6.10.1. Overview
    • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.10.3. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.10.4. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6.11. Algeria
    • 10.6.11.1. Overview
    • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.11.3. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.11.4. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6.12. Egypt
    • 10.6.12.1. Overview
    • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.12.3. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.12.4. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6.13. Rest of MEA
    • 10.6.13.1. Overview
    • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.13.3. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.13.4. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- AI in Cancer Diagnostics Industry

• 11.1. Competitive Dashboard
• 11.2. Company Profiles
  • 11.2.1. EarlySign
  • 11.2.2. Cancer Center.ai
  • 11.2.3. Microsoft
  • 11.2.4. Flatiron
  • 11.2.5. Path AI
  • 11.2.6. Therapixel
  • 11.2.7. Tempus
  • 11.2.8. Paige AI, Inc.
  • 11.2.9. Maxwell Plus
  • 11.2.10. Kheiron Medical Technologies Limited
  • 11.2.11. SkinVision
  • 11.2.12. Cancer Diagnostics Inc.
  • 11.2.13. Siemens Healthineers
  • 11.2.14. GE Healthcare
  • 11.2.15. Others

12. 360 Degree Analyst View

13. Appendix

• 13.1. Research Methodology
• 13.2. References
• 13.3. Abbreviations
• 13.4. Disclaimer
• 13.5. Contact Us